谷歌Chrome浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.

Shun Ishido,Nobuharu Tamaki,Naoki Uchihara,Keito Suzuki,Yuki Tanaka,Haruka Miyamoto,Michiko Yamada,Hiroaki Matsumoto,Tsubasa Nobusawa,Taisei Keitoku,Kenta Takaura,Shohei Tanaka,Chiaki Maeyashiki,Yutaka Yasui,Yuka Takahashi,Kaoru Tsuchiya,Hiroyuki Nakanishi,Jun Itakura,Masayuki Kurosaki,Namiki Izumi

JGH open : an open access journal of gastroenterology and hepatology（2023）

引用 0|浏览24
暂无评分
摘要
Switching from ETV to TAF increases the CVR rate in patients with LLV or occasional detectable HBV DNA and could be an alternative treatment option.
更多
查看译文
关键词
chronic hepatitis,tenofovir alafenamide,entecavir,virological response,complete virological response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要